SMAD2 and melanoma: Because we had identified the SMAD2/4/SKI complex as relevant for the inhibitory action of nelfinavir on PAX3 transcription, and nelfinavir counteracted the MAPKi-induced tolerance in melanoma cells (see Figure 3C), we wanted to identify the link between the SMAD/SKI suppressor complex and MAPK signaling.